Health & Social CareIndustrial Innovation
Mr Andrew FowlieScottish Government
Health Innovations TeamSHINE North Sea Region Program 2014 2020
Imaging
Non Imaging Diagnostics
In VitroDiagnostics
Surgical & Clinical
EquipmentTherapeutic
Devices -Active
Therapeutic Devices -PassiveDigital
Health & Care
Science , Clinical &
Technology
Scotlands Medical Technologies Landscape
http://www.vascutek.com/http://www.aurumbiosciences.com/about-us/
Areas of Strength
Connected Healthcare
Precision Medicine
Pharma Services
Medical Technologies
Regenerative Medicine
Animal Health
Areas of Strength
Scotland hosts one of the most sizeable Life Sciences clusters in Europe
Pharmaceutical Services in Scotland % of Pharmaceutical Services Sector by
Company
1111
13
1822
14
713
Drug Discovery
Pre Clinical CRO
Clinical CRO
Pharmaceutical ManufactureSpecialist Product
Specialist Service
Clinical Trials Support
Statistical, Regulatory, Logistics & Quality
Over 150 companies, employing more than 9,000people with a turnover of 1.2 bn
A comprehensive supply chain supporting every stage of drug discovery, development and manufacturing
Refined testing and manufacturing expertise in fast-growing antibody-drug conjugate (ADC) market
Global leaders in pharmaceutical manufacture AMRI, BASF, Capsugel, GSK and SAFC recognize the advantages of operating in Scotland
Preferred clinical trial site for Pfizer, PPD, Quintiles and Roche
Responsive tissue acquisition and data linkage
Pharmaceutical Services in Scotland
Chart1
11
11
13
18
22
14
7
13
Revenue Shares by Subsectors
Sheet1
Revenue Shares by Subsectors
Drug Discovery11
Pre Clinical CRO11
Clinical CRO13
Pharmaceutical Manufacture18
Specialist Product22
Specialist Service14
Clinical Trials Support7
Statistical, Regulatory, Logistics & Quality13
Strengths of Medical Technologies in Scotland
% of Medtech Sector by Company Over c250 companies employing over 9,000 people and with a turnover of 1.2bn
Comprehensive medtech supply chain - c100+ companies, with capabilities in design, prototype and manufacture
Strong history of healthcare innovation
Ideal testing environment for the development of new medical technologies & diagnostics with NHS facilitated access to patients & professionals
Global leaders in medtech manufacture J&J, Medtronic, Terumo, Toshiba, Nikon, Ossr recognise the advantages of operating in Scotland.
Fast and supportive regulatory system
8%8%
12%
13%
3%6%
15%
12%
23%
Imaging
Non Imaging Diagnostics(exc in vitro diagnostics)In vitro Diagnostics
Surgical Instruments andOther Clinical EquipmentResearch Equipment
Active / Drug DeliveryTherapeutic DevicesPassive TherapeuticDevicesPersonal Care / AssistedLiving
Strengths of Medical Technologies in Scotland
Scotlands Precision Medicine LandscapeScotlands Precision Medicine Landscape
Improving Quality, Reducing Costs
1 2 3 4 5
QUALITY INITIATIVES COST REDUCTION PROGRAMMES
Costs more cost neutral improves quality quality neutral reduces qualityreduces costs
Connected and Distributed Care Models
New Models of Care:
Accelerating the Pace of Change
Business Opportunities
Technology Barriers
1100 known mobile apps available that may support people with diabetes
2% of people use them 40% Smart Phone use in Scotland Low level of health use of technology for remote support
Technology Barriers
1. Fears around privacy (e.g. of patients own data) and regulation;2. Perceived or real difficulty in achieving clinical benefit;3. Perceived or real difficulty in achieving economic benefit;4. Poor integration with health care processes;5. The apparent existence of too many mobile options available with limited evidence behind them, making it difficult for patients to know which, if any, would be useful.
Convergence
mobile computing (smart phone as a diagnostic tool/ body worn /in vitro monitoring)
digital manufacturing (3d printing etc) robotics (surgery, dispensing, devices etc) artificial intelligence (anticipatory care, forecasting,
informed decision making etc) networks & sensors (remote ECG, cloud enabled care etc) systems biology (regenerative medicine, genomics etc)
Policy and Resources
1. Core Health and Social Care Delivery Plan and usual range of support plans
2. Economic Plan- Innovation and Productivity-Scottish Government- CAN DO
3. UK Industrial Strategy4. Post BREXIT Emerging Policy
Innovation Supply Process
Registration Health Technology Assessment (HTA) Implementation
National /local procurement
Registration and Signposting
Industry/Enterprise input
Link to NHS/Social Care
Support for IMTO process
Early engagement and advice
Key stages of an innovation process for Scotland include the following;
Links to Network,
Performance and Delivery
HIAP Innovation stakeholders
SHTG
Demand Led - Open Innovation
THE KEY DRIVER OF INNOVATION IS SOLVING CUSTOMER PROBLEMS THOUGH CONTRACTS IN A
BUSINESS ENVIRONMENT
Creating Markets for Things that Dont Exist
David Connell
Cambridge University Centre for Business Research
OPEN INNOVATION
The process of innovating with others for shared risk and reward to produce mutual benefits for each
organisation, creating new products, processes or ideas that could not otherwise have been achieved
alone, or enabling them to be achieved more quickly, cheaply or efficiently
Vision:Build our life science industry into a global hub
that makes the UK the home of clinical research and medical innovation
A globally-unique and internationally competitive life sciences ecosystem supported by collaboration across industry, the NHS, academia and research funders to delivering health and wealth
Ensuring the UK has the talent and skills to underpin future life sciences success
SKILLS
Building on the Accelerated Access Review, enabling the
NHS to embrace cost-effective innovations for patients
Supporting collaboration on real world evidence, enabling
innovators and the NHS to research new technologies
Building on strengths in discovery research and
supporting translation of our world-class science base
Enabling SME growth and supporting infrastructure
across the regions of the UK
NHS DIGITALSCIENCE GROWTH
Health Advanced Research Programme: Bringing together a coalition of funders to anticipate a future vision of healthcare and create new industries in the UK based on grand challenges, such as healthy ageing, diagnosis-led healthcare, and AI
A joint programme of delivery between industry, NHS and Government to monitor and oversee implementation will be agreed through a Life Sciences Sector Deal
Working with the best global partners and driving new opportunities for trade and investment
GLOBAL BRITAIN
REGULATION
Securing patient safety and delivering the best ecosystem for life sciences
An industry-led vision for the life sciences sector that will be underpinned by new investment and create the foundations to support growth and attract new industries into the UK in the post-Brexit environment
Life Sciences Industrial Strategy
Our partnership
13/10/2017 Slide 32
Health & Social CareIndustrial InnovationDianummer 2Scotlands Medical Technologies LandscapeAreas of StrengthPharmaceutical Services in ScotlandStrengths of Medical Technologies in ScotlandScotlands Precision Medicine LandscapeDianummer 8Dianummer 9Dianummer 10Dianummer 11Dianummer 12Dianummer 13Dianummer 14Dianummer 15Dianummer 16Dianummer 17Dianummer 18Dianummer 19Technology BarriersTechnology Barriers Convergence Dianummer 23Policy and ResourcesDianummer 25Innovation Supply ProcessDianummer 27Demand Led - Open InnovationOPEN INNOVATIONDianummer 30Life Sciences Industrial StrategyOur partnership
Top Related